Non-receptor cytotoxic pathways

Non-receptor cytotoxic pathways encompass a broad category of biological and pharmacological mechanisms that induce cell death without the primary involvement of cell-surface or nuclear receptor signaling (National Cancer Institute, 2023). In clinical pharmacology, this term typically refers to the action of traditional chemotherapeutic agents that directly damage cellular components, such as alkylating agents that cross-link DNA, antimetabolites that disrupt nucleotide metabolism, and microtubule inhibitors that halt mitosis (NCBI Bookshelf, 2022; StatPearls, 2023). In an immunological context, these pathways also include the direct delivery of cytotoxic granules containing perforin and granzymes by effector T cells and Natural Killer cells, which induce apoptosis through pore formation and protease activation (PubMed, 2021). Because these mechanisms target fundamental processes required for cell survival and division, they are highly effective against rapidly proliferating malignant cells but often lack the precision of modern targeted therapies. Consequently, drugs utilizing these pathways are frequently associated with significant systemic toxicities in healthy tissues, such as the bone marrow and intestinal lining, leading to a narrow therapeutic window (NIH, 2023).

Other names

Non-receptor mediated cytotoxicityDirect cytotoxic mechanismsNon-specific cytotoxic pathwaysChemotherapeutic cell death pathways

Induction of cell death through direct interference with DNA integrity, nucleic acid synthesis, or structural proteins (e.g., tubulin) rather than through primary receptor-mediated signaling (National Cancer Institute, 2023).